U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 79

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:128709778
GRCh38:
Chr11:128839883
KCNJ1V121M, V138M, V140MBartter disease type 2Uncertain significancecriteria provided, single submitter
2.
GRCh37:
Chr11:128710147
GRCh38:
Chr11:128840252
KCNJ1T15A, T17ABartter disease type 2Uncertain significance
(Jun 24, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr11:128710059
GRCh38:
Chr11:128840164
KCNJ1D27G, D44G, D46GBartter disease type 2Uncertain significance
(Jun 17, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr11:128709019
GRCh38:
Chr11:128839124
KCNJ1Bartter disease type 2Uncertain significance
(May 17, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr11:128709626
GRCh38:
Chr11:128839731
KCNJ1K171N, K188N, K190NBartter disease type 2Uncertain significance
(Oct 19, 2020)
criteria provided, single submitter
6.
GRCh37:
Chr11:128709837
GRCh38:
Chr11:128839942
KCNJ1P101L, P118L, P120LBartter disease type 2Uncertain significance
(Oct 19, 2020)
criteria provided, single submitter
7.
GRCh37:
Chr11:128709888
GRCh38:
Chr11:128839993
KCNJ1A101V, A103V, A84VBartter disease type 2Likely pathogenic
(Jun 7, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr11:128712281
GRCh38:
Chr11:128842386
KCNJ1T11Mnot provided, Bartter disease type 2Uncertain significance
(Mar 2, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr11:128709120
GRCh38:
Chr11:128839225
KCNJ1L359R, L357R, L340RInborn genetic diseases, not provided, Bartter disease type 2
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr11:128709841
GRCh38:
Chr11:128839946
KCNJ1T119A, T117A, T100AInborn genetic diseases, not provided, Bartter disease type 2
Uncertain significance
(Jul 5, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr11:128710105
GRCh38:
Chr11:128840210
KCNJ1R12C, R31C, R29Cnot provided, Bartter disease type 2Uncertain significance
(Oct 5, 2021)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr11:128709633
GRCh38:
Chr11:128839738
KCNJ1R169H, R186H, R188Hnot provided, Bartter disease type 2Uncertain significance
(May 25, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr11:128709138
GRCh38:
Chr11:128839243
KCNJ1P334fs, P351fs, P353fsBartter disease type 2Uncertain significance
(Jan 22, 2021)
criteria provided, single submitter
14.
GRCh37:
Chr11:128709589
GRCh38:
Chr11:128839694
KCNJ1R184W, R201W, R203WBartter disease type 2Likely pathogenic
(Jan 3, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr11:128709634
GRCh38:
Chr11:128839739
KCNJ1R169S, R186S, R188Snot provided, Bartter disease type 2Uncertain significance
(Jan 23, 2023)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr11:128709297
GRCh38:
Chr11:128839402
KCNJ1T281R, T298R, T300RBartter disease type 2Uncertain significance
(Jun 26, 2020)
criteria provided, single submitter
17.
GRCh37:
Chr11:128709867
GRCh38:
Chr11:128839972
KCNJ1P108L, P110L, P91LBartter disease type 2Likely pathogenic
(Jul 19, 2021)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr11:128709023
GRCh38:
Chr11:128839128
KCNJ1M389I, M372I, M391IBartter disease type 2, not providedUncertain significance
(May 10, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr11:128710052
GRCh38:
Chr11:128840157
KCNJ1Bartter disease type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
20.
GRCh37:
Chr11:128709983
GRCh38:
Chr11:128840088
KCNJ1Bartter disease type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr11:128709618
GRCh38:
Chr11:128839723
KCNJ1T193M, T191M, T174MBartter disease type 2, not providedConflicting interpretations of pathogenicity
(Sep 12, 2022)
criteria provided, conflicting interpretations
22.
GRCh37:
Chr11:128709433
GRCh38:
Chr11:128839538
KCNJ1A236T, A253T, A255TBartter disease type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
23.
GRCh37:
Chr11:128708283
GRCh38:
Chr11:128838388
KCNJ1Bartter disease type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
24.
GRCh37:
Chr11:128708219
GRCh38:
Chr11:128838324
KCNJ1Bartter disease type 2Likely benign
(Jan 13, 2018)
criteria provided, single submitter
25.
GRCh37:
Chr11:128708156
GRCh38:
Chr11:128838261
KCNJ1Bartter disease type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
26.
GRCh37:
Chr11:128708052
GRCh38:
Chr11:128838157
KCNJ1Bartter disease type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
27.
GRCh37:
Chr11:128709341
GRCh38:
Chr11:128839446
KCNJ1Bartter disease type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
28.
GRCh37:
Chr11:128709297
GRCh38:
Chr11:128839402
KCNJ1T300I, T298I, T281IBartter disease type 2, not providedUncertain significance
(Jul 14, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr11:128709193
GRCh38:
Chr11:128839298
KCNJ1G333R, G335R, G316RBartter disease type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
30.
GRCh37:
Chr11:128710112
GRCh38:
Chr11:128840217
KCNJ1Bartter disease type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
31.
GRCh37:
Chr11:128708937
GRCh38:
Chr11:128839042
KCNJ1Bartter disease type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
32.
GRCh37:
Chr11:128709538
GRCh38:
Chr11:128839643
KCNJ1L218F, L220F, L201FBartter syndrome, not provided, Bartter disease type 2
Conflicting interpretations of pathogenicity
(Mar 1, 2023)
criteria provided, conflicting interpretations
33.
GRCh37:
Chr11:128709537
GRCh38:
Chr11:128839642
KCNJ1L220R, L201R, L218RBartter disease type 2Likely pathogenic
(Jul 1, 2018)
criteria provided, single submitter
34.
GRCh37:
Chr11:128709588
GRCh38:
Chr11:128839693
KCNJ1R201Q, R203Q, R184QBartter disease type 2Likely pathogenic
(Jul 1, 2018)
criteria provided, single submitter
35.
GRCh37:
Chr11:128709561
GRCh38:
Chr11:128839666
KCNJ1R193P, R212P, R210PBartter disease type 2, not providedUncertain significance
(Mar 25, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr11:128712297
GRCh38:
Chr11:128842402
KCNJ1R6Wnot provided, Bartter disease type 2Uncertain significance
(Apr 23, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr11:128709887
GRCh38:
Chr11:128839992
KCNJ1not provided, Bartter disease type 2Benign/Likely benign
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr11:128709341
GRCh38:
Chr11:128839446
KCNJ1Bartter disease type 2, not providedConflicting interpretations of pathogenicity
(Aug 26, 2022)
criteria provided, conflicting interpretations
39.
GRCh37:
Chr11:128709635
GRCh38:
Chr11:128839740
KCNJ1K168fs, K185fs, K187fsBartter disease type 2Likely pathogenic
(Sep 19, 2019)
criteria provided, single submitter
40.
GRCh37:
Chr11:128709984
GRCh38:
Chr11:128840089
KCNJ1T52M, T71M, T69Mnot provided, Bartter syndrome, Bartter disease type 2
Conflicting interpretations of pathogenicity
(Mar 24, 2023)
criteria provided, conflicting interpretations
41.
GRCh37:
Chr11:128709513
GRCh38:
Chr11:128839618
KCNJ1G209E, G228E, G226EBartter disease type 2Uncertain significance
(Sep 7, 2017)
criteria provided, single submitter
42.
GRCh37:
Chr11:128709272
GRCh38:
Chr11:128839377
KCNJ1C289*, C308*, C306*Bartter disease type 2, not providedPathogenic/Likely pathogenic
(May 25, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr11:128709184
GRCh38:
Chr11:128839289
KCNJ1R319*, R338*, R336*not provided, Bartter disease type 2Likely pathogenic
(Jul 14, 2021)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr11:128709434
GRCh38:
Chr11:128839539
KCNJ1not specified, not provided, Bartter disease type 2
Conflicting interpretations of pathogenicity
(Oct 10, 2022)
criteria provided, conflicting interpretations
45.
GRCh37:
Chr11:128712280
GRCh38:
Chr11:128842385
KCNJ1not specified, not provided, Bartter disease type 2
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
46.
GRCh37:
Chr11:128709877
GRCh38:
Chr11:128839982
KCNJ1K88*, K107*, K105*Bartter disease type 2Pathogenicno assertion criteria provided
47.
GRCh37:
Chr11:128712417
GRCh38:
Chr11:128842522
KCNJ1Bartter disease type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
48.
GRCh37:
Chr11:128712356
GRCh38:
Chr11:128842461
KCNJ1Bartter disease type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
49.
GRCh37:
Chr11:128712326
GRCh38:
Chr11:128842431
KCNJ1Bartter disease type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr11:128710122
GRCh38:
Chr11:128840227
KCNJ1R25Q, R6Q, R23QBartter disease type 2, not providedConflicting interpretations of pathogenicity
(Sep 29, 2022)
criteria provided, conflicting interpretations
51.
GRCh37:
Chr11:128710104
GRCh38:
Chr11:128840209
KCNJ1R12H, R31H, R29HBartter disease type 2, not providedConflicting interpretations of pathogenicity
(Jul 6, 2022)
criteria provided, conflicting interpretations
52.
GRCh37:
Chr11:128709571
GRCh38:
Chr11:128839676
KCNJ1L190F, L209F, L207FBartter disease type 2, not providedLikely benign
(Mar 4, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr11:128709562
GRCh38:
Chr11:128839667
KCNJ1R193*, R212*, R210*Bartter disease type 2Conflicting interpretations of pathogenicity
(Sep 9, 2020)
criteria provided, conflicting interpretations
54.
GRCh37:
Chr11:128709407
GRCh38:
Chr11:128839512
KCNJ1Bartter disease type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
55.
GRCh37:
Chr11:128709347
GRCh38:
Chr11:128839452
KCNJ1Bartter disease type 2, not providedBenign/Likely benign
(Jun 29, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr11:128709302
GRCh38:
Chr11:128839407
KCNJ1Bartter disease type 2, not providedConflicting interpretations of pathogenicity
(Jul 9, 2022)
criteria provided, conflicting interpretations
57.
GRCh37:
Chr11:128709216
GRCh38:
Chr11:128839321
KCNJ1P308L, P327L, P325LBartter disease type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
58.
GRCh37:
Chr11:128709004
GRCh38:
Chr11:128839109
KCNJ1Bartter disease type 2, not providedLikely benign
(Feb 3, 2021)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr11:128708932
GRCh38:
Chr11:128839037
KCNJ1Bartter disease type 2Likely benign
(Jan 12, 2018)
criteria provided, single submitter
60.
GRCh37:
Chr11:128708672
GRCh38:
Chr11:128838777
KCNJ1Bartter disease type 2Benign
(Jan 12, 2018)
criteria provided, single submitter
61.
GRCh37:
Chr11:128708638
GRCh38:
Chr11:128838743
KCNJ1Bartter disease type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
62.
GRCh37:
Chr11:128708568
GRCh38:
Chr11:128838673
KCNJ1Bartter disease type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
63.
GRCh37:
Chr11:128708513
GRCh38:
Chr11:128838618
KCNJ1Bartter disease type 2Likely benign
(Jan 13, 2018)
criteria provided, single submitter
64.
GRCh37:
Chr11:128708467
GRCh38:
Chr11:128838572
KCNJ1Bartter disease type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
65.
GRCh37:
Chr11:128708056
GRCh38:
Chr11:128838161
KCNJ1Bartter disease type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
66.
GRCh37:
Chr11:128709105
GRCh38:
Chr11:128839210
KCNJ1D345G, D362G, D364GInborn genetic diseases, not provided, Bartter disease type 2
Uncertain significance
(May 16, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr11:128709634
GRCh38:
Chr11:128839739
KCNJ1R169C, R188C, R186Cnot specified, Bartter disease type 2, Inborn genetic diseases,
not provided
Conflicting interpretations of pathogenicity
(Sep 7, 2022)
criteria provided, conflicting interpretations
68.
GRCh37:
Chr11:128709877
GRCh38:
Chr11:128839982
KCNJ1K88E, K107E, K105EBartter disease type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
69.
GRCh37:
Chr11:128709897
GRCh38:
Chr11:128840002
KCNJ1Y81C, Y100C, Y98Cnot provided, Bartter disease type 2Uncertain significance
(Apr 21, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr11:128709824
GRCh38:
Chr11:128839929
KCNJ1N105K, N124K, N122KBartter disease type 2Pathogenic
(Sep 11, 1998)
no assertion criteria provided
71.
GRCh37:
Chr11:128709874
GRCh38:
Chr11:128839979
KCNJ1D108H, D89H, D106HBartter disease type 2Pathogenic
(Jan 23, 1997)
no assertion criteria provided
72.
GRCh37:
Chr11:128709696
GRCh38:
Chr11:128839801
KCNJ1G167E, G148E, G165EBartter disease type 2Pathogenic
(Jan 1, 1997)
no assertion criteria provided
73.
GRCh37:
Chr11:128709604
GRCh38:
Chr11:128839709
KCNJ1A198T, A179T, A196TBartter disease type 2Pathogenic
(Jan 1, 1997)
no assertion criteria provided
74.
GRCh37:
Chr11:128709126
GRCh38:
Chr11:128839231
KCNJ1M338T, M355T, M357Tnot specified, not providedBenign/Likely benign
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr11:128709555
GRCh38:
Chr11:128839660
KCNJ1A195V, A212V, A214VBartter disease type 2Likely pathogenic
(Mar 14, 2022)
criteria provided, single submitter
76.
KCNJ1Bartter disease type 2Pathogenic
(Oct 1, 1996)
no assertion criteria provided
77.
GRCh37:
Chr11:128709539
GRCh38:
Chr11:128839644
KCNJ1S200R, S219R, S217RBartter disease type 2Pathogenic
(Jun 1, 1998)
no assertion criteria provided
78.
GRCh37:
Chr11:128710096-128710097
GRCh38:
Chr11:128840201-128840202
KCNJ1G15fs, G32fs, G34fsBartter disease type 2Pathogenic
(Oct 1, 1996)
no assertion criteria provided
79.
GRCh37:
Chr11:128709959
GRCh38:
Chr11:128840064
KCNJ1Y60*, Y77*, Y79*Bartter disease type 2Pathogenic
(Oct 1, 1996)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination